{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:24:35Z","timestamp":1787869475502,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mayocp.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T09:26:45Z","timestamp":1532856405000},"page":"1236-1246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo\u00a0Cancer Incidence Across Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"93","author":[{"given":"Mamatha","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Dierkhising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly D.S.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2018.04.025_bib1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mayocp.2018.04.025_bib2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.transproceed.2004.12.077","article-title":"Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile","volume":"37","author":"Jain","year":"2005","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2018.04.025_bib3","first-page":"1247","article-title":"Malignancy following liver transplantation: a report from the Australian Combined Liver Transplant Registry","volume":"27","author":"Sheil","year":"1995","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.mayocp.2018.04.025_bib4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1046\/j.1600-6143.2003.00227.x","article-title":"Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy","volume":"3","author":"Herrero","year":"2003","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.mayocp.2018.04.025_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/jlts.2001.27084","article-title":"Analysis of causes of death in liver transplant recipients who survived more than 3 years","volume":"7","author":"Pruthi","year":"2001","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.mayocp.2018.04.025_bib6","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.transproceed.2006.07.029","article-title":"Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver\u00a0transplant experience","volume":"38","author":"Lukes","year":"2006","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.mayocp.2018.04.025_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/jlts.2001.28744","article-title":"Risk factors for development of de novo neoplasia after liver transplantation","volume":"7","author":"Xiol","year":"2001","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.mayocp.2018.04.025_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0002-9610(01)00595-5","article-title":"Late mortality after orthotopic liver transplantation","volume":"181","author":"Rabkin","year":"2001","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2018.04.025_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1237::AID-CNCR25>3.0.CO;2-5","article-title":"Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors","volume":"83","author":"Kelly","year":"1998","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2018.04.025_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(00)00077-5","article-title":"Increased cancer risk after liver transplantation: a population-based study","volume":"34","author":"Haagsma","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.04.025_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/lt.500020109","article-title":"Posttransplantation de novo tumors in liver allograft recipients","volume":"2","author":"Penn","year":"1996","journal-title":"Liver Transpl Surg"},{"issue":"11","key":"10.1016\/j.mayocp.2018.04.025_bib12","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/lt.21554","article-title":"Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study","volume":"14","author":"Jiang","year":"2008","journal-title":"Liver Transpl"},{"issue":"17","key":"10.1016\/j.mayocp.2018.04.025_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2018.04.025_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2 suppl","key":"10.1016\/j.mayocp.2018.04.025_bib15","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"issue":"9103","key":"10.1016\/j.mayocp.2018.04.025_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mayocp.2018.04.025_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.mayocp.2018.04.025_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.04.025_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alberu","year":"2011","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.mayocp.2018.04.025_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.mayocp.2018.04.025_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2018.04.025_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2018.04.025_bib23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mayocp.2018.04.025_bib24","series-title":"SEER Cancer Statistics Review, 1975-2013","year":"2016"},{"issue":"7","key":"10.1016\/j.mayocp.2018.04.025_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.mayocp.2018.04.025_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3892\/mmr.2014.2302","article-title":"Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4\/SDF1alpha expression in\u00a0vivo","volume":"10","author":"Zhu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mayocp.2018.04.025_bib27","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"105","key":"10.1016\/j.mayocp.2018.04.025_bib28","first-page":"115","article-title":"Switching to sirolimus monotherapy for de novo tumors after liver transplantation: a preliminary experience","volume":"58","author":"Jimenez-Romero","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"9","key":"10.1016\/j.mayocp.2018.04.025_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.healun.2013.06.022","article-title":"Tumor regression and sirolimus-based therapy\u00a0in lung transplantation","volume":"32","author":"Hillen","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.mayocp.2018.04.025_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/ctr.12430","article-title":"Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease","volume":"28","author":"Thimonier","year":"2014","journal-title":"Clin Transplant"},{"issue":"13","key":"10.1016\/j.mayocp.2018.04.025_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2018.04.025_bib32","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","article-title":"Sirolimus conversion for patients with posttransplant Kaposi's sarcoma","volume":"6","author":"Lebbe","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2018.04.025_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.510280404","article-title":"Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark","volume":"28","author":"Sorensen","year":"1998","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.mayocp.2018.04.025_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/tri.13011","article-title":"Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study","volume":"30","author":"Fattouh","year":"2017","journal-title":"Transpl Int"},{"issue":"23","key":"10.1016\/j.mayocp.2018.04.025_bib35","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618304427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T11:41:48Z","timestamp":1536061308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618304427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0025619618304427"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.04.025","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo\u00a0Cancer Incidence Across Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}